# Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities:  Guidance for Industry – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/repackaging-of-certain-human-drug-products-by-pharmacies-and-outsourcing-facilities-guidance-for-industry/c324ad2d-8447-448c-b0ed-664984cf9ba6

> FDA guidance document: Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities:  Guidance for Industry. Issue date: January 13, 2017. Get complete insights and analysis.

---

## Details

- Title: Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-01-13
- Last Changed: 2020-04-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-1524">FDA-2014-D-1524</a>

## Related Documents

- [Abuse-Deterrent Opioids-Evaluation and Labeling](https://www.keypedia.com/guidances/guidance-document/abuse-deterrent-opioids-evaluation-and-labeling/0a716f45-a359-4eab-aacc-8fba6a24447e)
- [Residual Drug in Transdermal and Related Drug Delivery Systems:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/residual-drug-in-transdermal-and-related-drug-delivery-systems-guidance-for-industry/54698fcf-db58-4dd4-ac3a-81992e898cae)
- [Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation](https://www.keypedia.com/guidances/guidance-document/tablet-scoringnomenclature-labeling-and-data-for-evaluation/d4b6bb69-1a24-4ebd-be2e-a80b08473b39)
